Gregory Hagood

Gregory F. Hagood, CFA, is Senior Managing Director and Head of Investment Banking at SOLIC Capital Advisors. SOLIC’s firm biography says he is President of SOLIC Capital Advisors and oversees the firm’s investment banking practice, including M&A advisory, private placements of debt and equity, and valuation services.

Hagood has more than 30 years of investment banking experience across mergers, acquisitions and divestitures, private debt and equity placements, public equity offerings, valuation and fairness opinions. His sector experience includes healthcare, business and technology services, financial services, manufacturing and industrial services, and energy.

Before SOLIC and predecessor firm Navigant Capital Advisors, LLC, Hagood worked as an investment banker at SunTrust Robinson Humphrey. Earlier, he was a financial analyst at Paces Properties, a real estate developer in the southeastern United States.

He holds a Master’s of Management from Northwestern University’s J.L. Kellogg School of Management and a B.S. from the McIntire School of Commerce at the University of Virginia. He is a CFA charterholder, holds AIRA’s Certification in Distressed Business Valuation, is a Certified Insolvency & Restructuring Advisor, and holds FINRA Series 7, 24, 63 and 65 licenses.

• Hagood’s public profile is primarily that of an investment banker and special-situations advisor, not a conventional seed-stage angel investor. I found no verified public evidence that he personally invests at seed stage or writes angel checks.
• SOLIC’s investment banking practice focuses on “Mergers and Acquisitions,” “Capital Markets,” and “Liability Management and Capital Structuring Solutions,” including exclusive sale processes, buy-side advisory, distressed sales, institutional debt and equity private placements, DIP financing, balance-sheet restructuring and special committee advisory.
• In healthcare, SOLIC emphasizes complex provider environments with regulatory, reimbursement and capital constraints. Its healthcare practice cites 230+ healthcare engagements representing over $12 billion in capitalization.
• In a March 2026 article co-authored with Matthew Caine, Hagood argued that private equity can be constructive in healthcare when governed responsibly, providing “capital, operational expertise, and discipline” for providers that need modernization, technology upgrades, clinician recruitment and financial stability.
• The same article says conditions-based approval, transparency around ownership structures and limits on appropriate leverage are practical tools to preserve private-investment benefits while reducing harm to patient care and community interests.